Commonwealth Equity Services’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $923K | Buy |
197,743
+300
| +0.2% | +$1.4K | ﹤0.01% | 2640 |
|
|
2025
Q1 | $1.08M | Buy |
197,443
+10,000
| +5% | +$54.9K | ﹤0.01% | 2389 |
|
|
2024
Q4 | $635K | Hold |
187,443
| – | – | ﹤0.01% | 2771 |
|
|
2024
Q3 | $534K | Buy |
187,443
+440
| +0.2% | +$1.25K | ﹤0.01% | 2847 |
|
|
2024
Q2 | $421K | Hold |
187,003
| – | – | ﹤0.01% | 2987 |
|
|
2024
Q1 | $413K | Hold |
187,003
| – | – | ﹤0.01% | 2990 |
|
|
2023
Q4 | $439K | Buy |
187,003
+40,769
| +28% | +$95.7K | ﹤0.01% | 2834 |
|
|
2023
Q3 | $272K | Hold |
146,234
| – | – | ﹤0.01% | 3118 |
|
|
2023
Q2 | $383K | Hold |
146,234
| – | – | ﹤0.01% | 2839 |
|
|
2023
Q1 | $238 | Sell |
146,234
-1,000
| -0.7% | -$2 | ﹤0.01% | 3167 |
|
|
2022
Q4 | $195K | Hold |
147,234
| – | – | ﹤0.01% | 3243 |
|
|
2022
Q3 | $229K | Hold |
147,234
| – | – | ﹤0.01% | 3058 |
|
|
2022
Q2 | $226K | Hold |
147,234
| – | – | ﹤0.01% | 3093 |
|
|
2022
Q1 | $376K | Sell |
147,234
-50,000
| -25% | -$128K | ﹤0.01% | 2772 |
|
|
2021
Q4 | $577K | Buy |
197,234
+99,650
| +102% | +$292K | ﹤0.01% | 2407 |
|
|
2021
Q3 | $239K | Sell |
97,584
-3,000
| -3% | -$7.35K | ﹤0.01% | 3123 |
|
|
2021
Q2 | $409K | Buy |
100,584
+3,350
| +3% | +$13.6K | ﹤0.01% | 2630 |
|
|
2021
Q1 | $438K | Buy |
97,234
+2,000
| +2% | +$9.01K | ﹤0.01% | 2434 |
|
|
2020
Q4 | $468K | Buy |
95,234
+1,000
| +1% | +$4.91K | ﹤0.01% | 2195 |
|
|
2020
Q3 | $558K | Buy |
94,234
+2,300
| +3% | +$13.6K | ﹤0.01% | 1886 |
|
|
2020
Q2 | $244K | Buy |
91,934
+81,934
| +819% | +$217K | ﹤0.01% | 2435 |
|
|
2020
Q1 | $19K | Buy |
+10,000
| New | +$19K | ﹤0.01% | 2760 |
|